Leukoplakia, Oral

8 registered clinical trials studyying Leukoplakia, Oral — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Topical Imiquimod Treatment of Oral Dysplasia NCT07210775	University of Southern California	Phase 1 / Phase 2
Completed	Diagnostic Accuracy of lncRNA DQ786243 and miRNA146a in Saliva of Oral Potentially Malignant Lesions NCT05730855	Fayoum University	—
Withdrawn	This Study is to Evaluate the Safety and Pharmacokinetics of SBS-101 in Patients With Oral Premalignant Lesion NCT03939364	Skyline Biosciences	Phase 1
Unknown	Oral Potentially Malignant Disorders: Comparison Between Surgical Treatment and Wait and See Approach NCT04858100	University of Milan	N/A
Completed	Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia NCT03692325	Dana-Farber Cancer Institute	Phase 2
Completed	Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact NCT03239834	Vigilant Biosciences, Inc.	—
Completed	Infectious Aetiology of Potentially Malignant Disorders and Squamous Cell Carcinomas of the Oral Cavity NCT01636544	Institut Pasteur	N/A
Completed	A Randomized Study of Sulindac in Oral Premalignant Lesions NCT00299195	Memorial Sloan Kettering Cancer Center	N/A